Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
102.59
+1.84 (1.83%)
At close: Mar 6, 2026
SHA:688198 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 146.33 | 115.21 | 95.13 | 51.2 | Upgrade
|
| Depreciation & Amortization | - | 22.72 | 13.7 | 6.83 | 6.93 | Upgrade
|
| Other Amortization | - | 2.67 | 0.53 | 0.53 | 0.46 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0 | -0.06 | -0.01 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.05 | 0 | 0.02 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -10.75 | -17.87 | -22.3 | -15.9 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 2.39 | 1.46 | 1.1 | 0.81 | Upgrade
|
| Other Operating Activities | - | -13.68 | -5.36 | -0.03 | 0.17 | Upgrade
|
| Change in Accounts Receivable | - | -63.04 | -30.18 | -22.36 | -30.26 | Upgrade
|
| Change in Inventory | - | -17.84 | -3.42 | -9.52 | -5.61 | Upgrade
|
| Change in Accounts Payable | - | 39.29 | 30.82 | 14.34 | 15.96 | Upgrade
|
| Change in Other Net Operating Assets | - | 18.12 | 29.2 | 58.24 | 80.95 | Upgrade
|
| Operating Cash Flow | - | 136.23 | 141.17 | 128.85 | 76.49 | Upgrade
|
| Operating Cash Flow Growth | - | -3.50% | 9.56% | 68.44% | 50.69% | Upgrade
|
| Capital Expenditures | - | -163.26 | -128.63 | -104.83 | -72.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.02 | 0.31 | 0.09 | 0.02 | Upgrade
|
| Cash Acquisitions | - | -10.84 | -43.28 | - | - | Upgrade
|
| Investment in Securities | - | -235.4 | 237.72 | -29.16 | -8.56 | Upgrade
|
| Other Investing Activities | - | 133.24 | 13.18 | 18.88 | 16.13 | Upgrade
|
| Investing Cash Flow | - | -276.23 | 79.3 | -115.02 | -64.64 | Upgrade
|
| Long-Term Debt Repaid | - | -4.25 | -2.61 | -1.39 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -4.25 | -2.61 | -1.39 | - | Upgrade
|
| Issuance of Common Stock | - | 14.48 | 16.9 | 11.34 | 10.78 | Upgrade
|
| Common Dividends Paid | - | -109.26 | -67.84 | -48.22 | -19.2 | Upgrade
|
| Other Financing Activities | - | -0 | -0 | -0.04 | -0.87 | Upgrade
|
| Financing Cash Flow | - | -99.03 | -53.54 | -38.31 | -9.29 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.01 | -0 | 0 | - | Upgrade
|
| Net Cash Flow | - | -239.03 | 166.92 | -24.49 | 2.57 | Upgrade
|
| Free Cash Flow | - | -27.02 | 12.53 | 24.01 | 4.27 | Upgrade
|
| Free Cash Flow Growth | - | - | -47.80% | 462.20% | -90.08% | Upgrade
|
| Free Cash Flow Margin | - | -5.38% | 3.38% | 8.14% | 1.70% | Upgrade
|
| Free Cash Flow Per Share | - | -0.20 | 0.09 | 0.18 | 0.03 | Upgrade
|
| Cash Interest Paid | - | - | - | 0 | - | Upgrade
|
| Cash Income Tax Paid | - | 23.06 | 14.95 | 4.59 | 21.09 | Upgrade
|
| Levered Free Cash Flow | - | -83.75 | -43.52 | 2.12 | -2.35 | Upgrade
|
| Unlevered Free Cash Flow | - | -83.47 | -43.26 | 2.17 | -2.28 | Upgrade
|
| Change in Working Capital | - | -13.49 | 33.56 | 47.59 | 32.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.